Harish Kumar Mysore Nagaraj

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Cti Biopharma Corp., S'bio Pte Ltd, Cell Therapeutics, Inc.. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harish Kumar Mysore Nagaraj. Retrieved from https://idiyas.com/inventor/harish-kumar-mysore-nagaraj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 18(Granted Patents)

Company Filing History:

Cell Therapeutics, Inc.

patents

Years Active: 2012-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11135227 - Oxygen linked pyrimidine derivatives (2021-10-05),

2. 10517876 - Oxygen linked pyrimidine derivatives (2019-12-31),

3. 9573964 - Oxygen linked pyrimidine derivatives (2017-02-21),

4. 9133214 - Heteroalkyl linked pyrimidine derivatives (2015-09-15),

5. 8415338 - Oxygen linked pyrimidine derivatives (2013-04-09),

6. 8153632 - Oxygen linked pyrimidine derivatives (2012-04-10),

7. 8143255 - Heteroalkyl linked pyrimidine derivatives (2012-03-27),

Title: Harish Kumar Mysore Nagaraj: Innovator in Anti-Proliferative Agents

Introduction

Harish Kumar Mysore Nagaraj is a notable inventor based in Singapore, SG. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-proliferative agents. With a total of 7 patents to his name, his work has the potential to impact the treatment of various proliferative disorders.

Latest Patents

One of his latest patents involves oxygen linked pyrimidine derivatives. This invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More specifically, it focuses on oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds, and their uses in treating proliferative disorders. These compounds may serve as medicaments for treating a range of proliferative disorders, including tumors and cancers, as well as other conditions associated with kinases.

Career Highlights

Throughout his career, Harish has worked with prominent companies such as S*bio Pte Ltd and CTI Biopharma Corp. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and innovation in drug development.

Collaborations

Harish has collaborated with notable professionals in his field, including Anders Poulsen and Eric T Sun. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented inventions.

Conclusion

Harish Kumar Mysore Nagaraj stands out as an influential inventor in the realm of anti-proliferative agents. His innovative work and collaborations continue to pave the way for advancements in the treatment of serious health conditions.

Profile summary based on public USPTO records.